Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N115 Nasal Spray for Cough in Idiopathic Pulmonary Fibrosis
NCT06037408Phase 3Completed
- Sponsor
- Cellular Sciences
- Start
- Aug 2023
- Primary completion
- May 2024
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium pyruvate nasal spray in idiopathic pulmonary fibrosis (IPF), sponsored by Cellular Sciences. Started Aug 2023; status: completed.
02
Drugs
sodium pyruvate nasal spray
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT06037408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06037408.